RxDoctor Payments Data

Emily Banks

Physician Assistant · Kernersville, NCNPI 1518734953

Payments from drug & device makers

$2,311in general payments, 2019–2025

Across 90 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$415
  • Jazz Pharmaceuticals Inc.$336
  • Sanofi$245
  • Regeneron Healthcare Solutions, Inc.$175
  • Avadel CNS Pharmaceuticals, LLC$168
  • Insmed, Inc.$125
  • plus $848 from 15 others

What the payments were for

  • Food & beverage$2,09491%
  • Education$2179%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,311 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$20,503
Breo ElliptaFluticasone/Vilanterol15$8,337
SymbicortBudesonide/Formoterol Fumarate21$4,620
Albuterol Sulfate HfaAlbuterol Sulfate57$1,331
Ventolin HfaAlbuterol Sulfate18$960
Fluticasone Propionate29$636
Ipratropium Bromide11$237
Montelukast Sodium24$112
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$101
Prednisone49$95
Omeprazole13$95
Doxycycline Hyclate14$89
Azithromycin17$52

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$32$28,84046 claims
AstraZenecaSymbicort$415$4,62021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Kernersville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →